| 0 |
HEPATOBILIARY NEOPLASM |
1 |
0.1000 |
| 1 |
T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA |
1 |
0.0500 |
| 2 |
VASOGENIC CEREBRAL OEDEMA |
31 |
0.0431 |
| 3 |
DNA MISMATCH REPAIR PROTEIN GENE MUTATION |
1 |
0.0417 |
| 4 |
PERIPROSTHETIC JOINT INFECTION |
1 |
0.0417 |
| 5 |
RESPIRATORY TRACT NEOPLASM |
1 |
0.0417 |
| 6 |
SYNOVIAL FLUID ANALYSIS ABNORMAL |
1 |
0.0303 |
| 7 |
DISSEMINATED NOCARDIOSIS |
4 |
0.0288 |
| 8 |
URETERAL NEOPLASM |
2 |
0.0256 |
| 9 |
FOLLICULAR LYMPHOMA RECURRENT |
2 |
0.0250 |
| 10 |
FOLLICULAR LYMPHOMA |
21 |
0.0239 |
| 11 |
OSTEOMYELITIS BACTERIAL |
6 |
0.0219 |
| 12 |
TUMOUR FLARE |
14 |
0.0205 |
| 13 |
ACETABULUM FRACTURE |
7 |
0.0187 |
| 14 |
LOWER GASTROINTESTINAL PERFORATION |
1 |
0.0169 |
| 15 |
URINARY TRACT NEOPLASM |
1 |
0.0161 |
| 16 |
WRONG PRODUCT PROCURED |
1 |
0.0152 |
| 17 |
CYTOKINE RELEASE SYNDROME |
299 |
0.0149 |
| 18 |
ADENOVIRUS REACTIVATION |
2 |
0.0139 |
| 19 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
28 |
0.0127 |
| 20 |
KLEBSIELLA TEST POSITIVE |
8 |
0.0123 |
| 21 |
GENITOURINARY TRACT NEOPLASM |
1 |
0.0120 |
| 22 |
LOWER RESPIRATORY TRACT INFLAMMATION |
3 |
0.0112 |
| 23 |
SOFT TISSUE NEOPLASM |
1 |
0.0076 |
| 24 |
RETICULOCYTOPENIA |
1 |
0.0068 |
| 25 |
INTRA-ABDOMINAL PRESSURE INCREASED |
1 |
0.0064 |
| 26 |
PNEUMONIA PARAINFLUENZAE VIRAL |
1 |
0.0059 |
| 27 |
PNEUMONITIS CHEMICAL |
2 |
0.0057 |
| 28 |
LYMPHOMA TRANSFORMATION |
2 |
0.0056 |
| 29 |
B-CELL LYMPHOMA RECURRENT |
3 |
0.0055 |
| 30 |
NEUROLOGICAL SYMPTOM |
31 |
0.0054 |
| 31 |
MYCOTIC ENDOPHTHALMITIS |
1 |
0.0053 |
| 32 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
30 |
0.0051 |
| 33 |
ADULT FAILURE TO THRIVE |
1 |
0.0047 |
| 34 |
CITROBACTER INFECTION |
2 |
0.0047 |
| 35 |
CYTOMEGALOVIRUS GASTROENTERITIS |
1 |
0.0046 |
| 36 |
HYPOGAMMAGLOBULINAEMIA |
27 |
0.0041 |
| 37 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
1 |
0.0039 |
| 38 |
HERPES ZOSTER REACTIVATION |
1 |
0.0038 |
| 39 |
RESPIRATORY MONILIASIS |
1 |
0.0037 |
| 40 |
EFFUSION |
5 |
0.0037 |
| 41 |
GENITOURINARY TRACT INFECTION |
1 |
0.0035 |
| 42 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
1 |
0.0035 |
| 43 |
COVID-19 PNEUMONIA |
41 |
0.0035 |
| 44 |
PROCALCITONIN INCREASED |
4 |
0.0034 |
| 45 |
DUODENAL OBSTRUCTION |
1 |
0.0033 |
| 46 |
ASPERGILLUS TEST POSITIVE |
1 |
0.0032 |
| 47 |
INCARCERATED HERNIA |
1 |
0.0032 |
| 48 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
1 |
0.0030 |
| 49 |
DIFFUSE LARGE B-CELL LYMPHOMA |
23 |
0.0030 |
| 50 |
PULMONARY NECROSIS |
1 |
0.0029 |
| 51 |
PSEUDOMONAL SEPSIS |
5 |
0.0029 |
| 52 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
2 |
0.0028 |
| 53 |
HUMAN RHINOVIRUS TEST POSITIVE |
1 |
0.0027 |
| 54 |
MEDIASTINAL DISORDER |
1 |
0.0027 |
| 55 |
INFLAMMATORY MARKER INCREASED |
12 |
0.0024 |
| 56 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 57 |
LYMPH GLAND INFECTION |
1 |
0.0022 |
| 58 |
ANASTOMOTIC ULCER |
1 |
0.0022 |
| 59 |
PNEUMONIA CRYPTOCOCCAL |
2 |
0.0021 |
| 60 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
9 |
0.0020 |
| 61 |
ENCEPHALITIS HERPES |
1 |
0.0020 |
| 62 |
MYELOID LEUKAEMIA |
1 |
0.0020 |
| 63 |
ORBITAL OEDEMA |
1 |
0.0020 |
| 64 |
SPLENIC HAEMORRHAGE |
1 |
0.0020 |
| 65 |
ENTEROCOCCAL BACTERAEMIA |
2 |
0.0019 |
| 66 |
CORYNEBACTERIUM INFECTION |
1 |
0.0019 |
| 67 |
THERAPY PARTIAL RESPONDER |
29 |
0.0019 |
| 68 |
LYMPHOCYTOSIS |
4 |
0.0019 |
| 69 |
URINARY TRACT INFECTION PSEUDOMONAL |
1 |
0.0017 |
| 70 |
POST-ACUTE COVID-19 SYNDROME |
2 |
0.0016 |
| 71 |
BLOOD IMMUNOGLOBULIN G DECREASED |
4 |
0.0016 |
| 72 |
NECROTISING RETINITIS |
1 |
0.0016 |
| 73 |
NOCARDIOSIS |
4 |
0.0016 |
| 74 |
CHALAZION |
1 |
0.0016 |
| 75 |
BONE OPERATION |
1 |
0.0015 |
| 76 |
TUMOUR LYSIS SYNDROME |
13 |
0.0015 |
| 77 |
DERMATITIS PSORIASIFORM |
3 |
0.0015 |
| 78 |
IMMUNOGLOBULINS DECREASED |
2 |
0.0015 |
| 79 |
FUSARIUM INFECTION |
1 |
0.0014 |
| 80 |
RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS |
1 |
0.0013 |
| 81 |
HERPES ZOSTER DISSEMINATED |
1 |
0.0012 |
| 82 |
HAEMATOLOGICAL INFECTION |
3 |
0.0012 |
| 83 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
1 |
0.0012 |
| 84 |
CAMPYLOBACTER INFECTION |
1 |
0.0012 |
| 85 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
1 |
0.0012 |
| 86 |
RETINITIS |
2 |
0.0012 |
| 87 |
GASTROINTESTINAL NEOPLASM |
1 |
0.0012 |
| 88 |
GASTROINTESTINAL FISTULA |
1 |
0.0011 |
| 89 |
VASCULAR DEMENTIA |
1 |
0.0011 |
| 90 |
INTESTINAL PSEUDO-OBSTRUCTION |
1 |
0.0011 |
| 91 |
DISEASE PROGRESSION |
134 |
0.0011 |
| 92 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 93 |
PARVOVIRUS B19 INFECTION |
1 |
0.0011 |
| 94 |
MUSCLE SWELLING |
1 |
0.0011 |
| 95 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
8 |
0.0011 |
| 96 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 97 |
DILATED CARDIOMYOPATHY |
1 |
0.0010 |
| 98 |
BREAST NEOPLASM |
1 |
0.0010 |
| 99 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 100 |
OCULAR TOXICITY |
1 |
0.0009 |
| 101 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 102 |
CENTRAL NERVOUS SYSTEM INFECTION |
1 |
0.0009 |
| 103 |
LUMBAR VERTEBRAL FRACTURE |
4 |
0.0009 |
| 104 |
INTERCEPTED MEDICATION ERROR |
4 |
0.0009 |
| 105 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 106 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 107 |
PNEUMONIA INFLUENZAL |
1 |
0.0008 |
| 108 |
CHOLECYSTITIS |
10 |
0.0008 |
| 109 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 110 |
UPPER RESPIRATORY TRACT INFLAMMATION |
1 |
0.0008 |
| 111 |
ENCEPHALITIS VIRAL |
1 |
0.0008 |
| 112 |
CYTOPENIA |
10 |
0.0008 |
| 113 |
ORAL MUCOSA EROSION |
1 |
0.0008 |
| 114 |
DISORIENTATION |
32 |
0.0008 |
| 115 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 116 |
GASTROENTERITIS NOROVIRUS |
1 |
0.0008 |
| 117 |
RECURRENT CANCER |
3 |
0.0007 |
| 118 |
ORAL FUNGAL INFECTION |
2 |
0.0007 |
| 119 |
ALVEOLITIS |
1 |
0.0007 |
| 120 |
PERIORBITAL SWELLING |
4 |
0.0007 |
| 121 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
2 |
0.0007 |
| 122 |
NEUTROPENIA |
96 |
0.0007 |
| 123 |
POST HERPETIC NEURALGIA |
1 |
0.0007 |
| 124 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 125 |
WRONG PATIENT RECEIVED PRODUCT |
2 |
0.0007 |
| 126 |
PNEUMONITIS |
18 |
0.0007 |
| 127 |
NEOPLASM SKIN |
1 |
0.0006 |
| 128 |
HEPATITIS B REACTIVATION |
2 |
0.0006 |
| 129 |
PNEUMONIA VIRAL |
2 |
0.0006 |
| 130 |
CRYPTOCOCCOSIS |
1 |
0.0006 |
| 131 |
SPLENIC RUPTURE |
1 |
0.0006 |
| 132 |
SYSTEMIC INFECTION |
1 |
0.0006 |
| 133 |
CYTOMEGALOVIRUS INFECTION |
10 |
0.0006 |
| 134 |
SPLENOMEGALY |
7 |
0.0006 |
| 135 |
NEOPLASM RECURRENCE |
2 |
0.0006 |
| 136 |
INFARCTION |
4 |
0.0006 |
| 137 |
OPHTHALMIC HERPES ZOSTER |
1 |
0.0006 |
| 138 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 139 |
INTERVERTEBRAL DISCITIS |
1 |
0.0005 |
| 140 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 141 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 142 |
PNEUMONIA FUNGAL |
2 |
0.0005 |
| 143 |
BACTERAEMIA |
6 |
0.0005 |
| 144 |
BLOOD DISORDER |
4 |
0.0005 |
| 145 |
CYSTITIS HAEMORRHAGIC |
2 |
0.0005 |
| 146 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 147 |
NEUTROPENIC COLITIS |
1 |
0.0005 |
| 148 |
VARICELLA ZOSTER VIRUS INFECTION |
1 |
0.0005 |
| 149 |
SUBILEUS |
1 |
0.0005 |
| 150 |
UPPER RESPIRATORY TRACT INFECTION |
22 |
0.0005 |
| 151 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 152 |
CD4 LYMPHOCYTES DECREASED |
1 |
0.0005 |
| 153 |
PSEUDOMONAS INFECTION |
4 |
0.0005 |
| 154 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 155 |
MALIGNANT NEOPLASM PROGRESSION |
46 |
0.0004 |
| 156 |
SKIN INFECTION |
5 |
0.0004 |
| 157 |
DIVERTICULUM INTESTINAL HAEMORRHAGIC |
1 |
0.0004 |
| 158 |
NEUTROPHIL COUNT DECREASED |
18 |
0.0004 |
| 159 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 160 |
PUSTULE |
1 |
0.0004 |
| 161 |
HAEMATOTOXICITY |
4 |
0.0004 |
| 162 |
INJECTION SITE REACTION |
28 |
0.0004 |
| 163 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 164 |
ORGANISING PNEUMONIA |
2 |
0.0004 |
| 165 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 166 |
KLEBSIELLA INFECTION |
2 |
0.0004 |
| 167 |
COVID-19 |
69 |
0.0004 |
| 168 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 169 |
LYMPHOMA |
6 |
0.0004 |
| 170 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
0.0004 |
| 171 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 172 |
TONSILLITIS |
2 |
0.0004 |
| 173 |
UVEITIS |
5 |
0.0004 |
| 174 |
PLEURITIC PAIN |
1 |
0.0004 |
| 175 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 176 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 177 |
PANCREATIC CARCINOMA METASTATIC |
1 |
0.0004 |
| 178 |
NEOPLASM |
4 |
0.0003 |
| 179 |
FEBRILE NEUTROPENIA |
23 |
0.0003 |
| 180 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 181 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
3 |
0.0003 |
| 182 |
STRESS CARDIOMYOPATHY |
2 |
0.0003 |
| 183 |
NEUROTOXICITY |
6 |
0.0003 |
| 184 |
INFUSION RELATED REACTION |
22 |
0.0003 |
| 185 |
CRANIOCEREBRAL INJURY |
1 |
0.0003 |
| 186 |
PNEUMONIA BACTERIAL |
3 |
0.0003 |
| 187 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 188 |
CHOLANGITIS |
2 |
0.0003 |
| 189 |
CLOSTRIDIUM DIFFICILE INFECTION |
7 |
0.0003 |
| 190 |
LEUKOPENIA |
16 |
0.0003 |
| 191 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 192 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
5 |
0.0003 |
| 193 |
LIVER ABSCESS |
1 |
0.0003 |
| 194 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 195 |
THROMBOCYTOPENIA |
34 |
0.0003 |
| 196 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 197 |
GENERAL PHYSICAL CONDITION ABNORMAL |
2 |
0.0003 |
| 198 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 199 |
LYMPHOEDEMA |
2 |
0.0003 |
| 200 |
BRONCHIOLITIS |
1 |
0.0003 |
| 201 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 202 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 203 |
LYMPHOPENIA |
4 |
0.0003 |
| 204 |
INTERCEPTED PRODUCT STORAGE ERROR |
1 |
0.0003 |
| 205 |
LIVER FUNCTION TEST INCREASED |
6 |
0.0003 |
| 206 |
ALANINE AMINOTRANSFERASE INCREASED |
17 |
0.0003 |
| 207 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 208 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
| 209 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 210 |
BACTERIAL INFECTION |
5 |
0.0003 |
| 211 |
HEPATIC FUNCTION ABNORMAL |
10 |
0.0003 |
| 212 |
RASH PAPULAR |
6 |
0.0003 |
| 213 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 214 |
CHEMOTHERAPY |
1 |
0.0003 |
| 215 |
SEPTIC SHOCK |
11 |
0.0003 |
| 216 |
ULCER |
4 |
0.0003 |
| 217 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 218 |
MYELOSUPPRESSION |
9 |
0.0002 |
| 219 |
ARTERIOSPASM CORONARY |
1 |
0.0002 |
| 220 |
RHINITIS |
2 |
0.0002 |
| 221 |
ENURESIS |
1 |
0.0002 |
| 222 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
7 |
0.0002 |
| 223 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 224 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 225 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 226 |
HYPERURICAEMIA |
1 |
0.0002 |
| 227 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 228 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 229 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 230 |
HYPERPYREXIA |
1 |
0.0002 |
| 231 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 232 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 233 |
NEOPLASM PROGRESSION |
8 |
0.0002 |
| 234 |
HYPOXIA |
8 |
0.0002 |
| 235 |
ASPARTATE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 236 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 237 |
HEPATOTOXICITY |
5 |
0.0002 |
| 238 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 239 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 240 |
OSTEOMYELITIS |
4 |
0.0002 |
| 241 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 242 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 243 |
DEEP VEIN THROMBOSIS |
14 |
0.0002 |
| 244 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 245 |
AGRANULOCYTOSIS |
4 |
0.0002 |
| 246 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 247 |
APPENDICITIS |
2 |
0.0002 |
| 248 |
CHOLELITHIASIS |
7 |
0.0002 |
| 249 |
PYREXIA |
72 |
0.0002 |
| 250 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 251 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 252 |
ENCEPHALOPATHY |
5 |
0.0002 |
| 253 |
LIVER DISORDER |
9 |
0.0002 |
| 254 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 255 |
SKIN EXFOLIATION |
17 |
0.0002 |
| 256 |
INFECTION |
29 |
0.0002 |
| 257 |
RASH MACULAR |
7 |
0.0002 |
| 258 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 259 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 260 |
ERYSIPELAS |
1 |
0.0002 |
| 261 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 262 |
DRUG RESISTANCE |
5 |
0.0002 |
| 263 |
SKIN NECROSIS |
1 |
0.0002 |
| 264 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 265 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 266 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 267 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 268 |
MELAENA |
4 |
0.0002 |
| 269 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 270 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 271 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 272 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 273 |
DRUG ERUPTION |
3 |
0.0002 |
| 274 |
HEPATITIS B |
1 |
0.0002 |
| 275 |
HEPATIC FAILURE |
5 |
0.0002 |
| 276 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 277 |
MENISCUS INJURY |
1 |
0.0002 |
| 278 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 279 |
PANCYTOPENIA |
9 |
0.0002 |
| 280 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 281 |
SWELLING OF EYELID |
1 |
0.0002 |
| 282 |
CELLULITIS |
8 |
0.0002 |
| 283 |
PNEUMONIA |
51 |
0.0002 |
| 284 |
NO ADVERSE EVENT |
28 |
0.0002 |
| 285 |
HERPES SIMPLEX |
1 |
0.0002 |
| 286 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 287 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
8 |
0.0002 |
| 288 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 289 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 290 |
RESPIRATORY FAILURE |
11 |
0.0002 |
| 291 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 292 |
MENINGITIS |
1 |
0.0001 |
| 293 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 294 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 295 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 296 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 297 |
JOINT EFFUSION |
1 |
0.0001 |
| 298 |
CHILLS |
17 |
0.0001 |
| 299 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 300 |
SEPSIS |
16 |
0.0001 |
| 301 |
EXTRASYSTOLES |
1 |
0.0001 |
| 302 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 303 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 304 |
NEUTROPENIC SEPSIS |
1 |
0.0001 |
| 305 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 306 |
C-REACTIVE PROTEIN INCREASED |
5 |
0.0001 |
| 307 |
HYPERGLYCAEMIA |
5 |
0.0001 |
| 308 |
GASTROENTERITIS |
2 |
0.0001 |
| 309 |
ASCITES |
4 |
0.0001 |
| 310 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 311 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 312 |
COLON CANCER |
2 |
0.0001 |
| 313 |
ATRIAL FIBRILLATION |
13 |
0.0001 |
| 314 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 315 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 316 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 317 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 318 |
NEUROPATHY PERIPHERAL |
12 |
0.0001 |
| 319 |
RENAL CYST |
1 |
0.0001 |
| 320 |
INTERSTITIAL LUNG DISEASE |
6 |
0.0001 |
| 321 |
HERPES ZOSTER |
7 |
0.0001 |
| 322 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 323 |
EMBOLISM |
1 |
0.0001 |
| 324 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 325 |
FUNGAL INFECTION |
4 |
0.0001 |
| 326 |
PERICARDITIS |
2 |
0.0001 |
| 327 |
HEPATIC ENZYME INCREASED |
8 |
0.0001 |
| 328 |
PYELONEPHRITIS |
1 |
0.0001 |
| 329 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 330 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 331 |
CARDIOTOXICITY |
1 |
0.0001 |
| 332 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 333 |
MYOSITIS |
1 |
0.0001 |
| 334 |
SYNOVITIS |
2 |
0.0001 |
| 335 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 336 |
UROSEPSIS |
1 |
0.0001 |
| 337 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 338 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 339 |
INFLUENZA |
12 |
0.0001 |
| 340 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 341 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 342 |
ATELECTASIS |
1 |
0.0001 |
| 343 |
RASH |
44 |
0.0001 |
| 344 |
HYPOTONIA |
1 |
0.0001 |
| 345 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 346 |
ANAEMIA |
18 |
0.0001 |
| 347 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 348 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 349 |
SKIN DISORDER |
3 |
0.0001 |
| 350 |
MALNUTRITION |
1 |
0.0001 |
| 351 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 352 |
OXYGEN SATURATION DECREASED |
5 |
0.0001 |
| 353 |
FISTULA |
1 |
0.0001 |
| 354 |
EYE INFECTION |
1 |
0.0001 |
| 355 |
OFF LABEL USE |
77 |
0.0001 |
| 356 |
DELIRIUM |
3 |
0.0001 |
| 357 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 358 |
VASCULITIS |
1 |
0.0001 |
| 359 |
BONE PAIN |
5 |
0.0001 |
| 360 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 361 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 362 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 363 |
POLYNEUROPATHY |
1 |
0.0001 |
| 364 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 365 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 366 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 367 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 368 |
PHARYNGITIS |
1 |
0.0001 |
| 369 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 370 |
SKIN ULCER |
2 |
0.0001 |
| 371 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 372 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 373 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 374 |
HYPOTENSION |
15 |
0.0001 |
| 375 |
DIVERTICULITIS |
2 |
0.0001 |
| 376 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 377 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 378 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 379 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 380 |
MENTAL DISORDER |
3 |
0.0001 |
| 381 |
FLUID OVERLOAD |
1 |
0.0001 |
| 382 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 383 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 384 |
TENDONITIS |
1 |
0.0001 |
| 385 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 386 |
BRAIN FOG |
1 |
0.0001 |
| 387 |
ARRHYTHMIA |
3 |
0.0001 |
| 388 |
HEAD INJURY |
2 |
0.0001 |
| 389 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 390 |
NIGHT SWEATS |
2 |
0.0001 |
| 391 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 392 |
LUNG DISORDER |
3 |
0.0001 |
| 393 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 394 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 395 |
DEATH |
52 |
0.0001 |
| 396 |
DRY SKIN |
8 |
0.0001 |
| 397 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 398 |
CANDIDA INFECTION |
1 |
0.0001 |
| 399 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 400 |
HEMIPARESIS |
1 |
0.0001 |
| 401 |
URINARY TRACT INFECTION |
10 |
0.0001 |
| 402 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 403 |
EOSINOPHILIA |
1 |
0.0001 |
| 404 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 405 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 406 |
RASH PRURITIC |
3 |
0.0001 |
| 407 |
HYPONATRAEMIA |
3 |
0.0001 |
| 408 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 409 |
COLITIS |
2 |
0.0001 |
| 410 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 411 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 412 |
DRUG INTOLERANCE |
5 |
0.0001 |
| 413 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 414 |
DERMATITIS |
1 |
0.0000 |
| 415 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 416 |
DECREASED APPETITE |
11 |
0.0000 |
| 417 |
SKIN CANCER |
1 |
0.0000 |
| 418 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 419 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 420 |
PRODUCT STORAGE ERROR |
4 |
0.0000 |
| 421 |
ANGIOEDEMA |
2 |
0.0000 |
| 422 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 423 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 424 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 425 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 426 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 427 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 428 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 429 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 430 |
SHOCK |
1 |
0.0000 |
| 431 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 432 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 433 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 434 |
CARDIAC DISORDER |
4 |
0.0000 |
| 435 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 436 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 437 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 438 |
HEPATITIS |
1 |
0.0000 |
| 439 |
ERYTHEMA |
8 |
0.0000 |
| 440 |
INFLAMMATION |
2 |
0.0000 |
| 441 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 442 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 443 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 444 |
BRADYCARDIA |
2 |
0.0000 |
| 445 |
CARDIAC FAILURE |
3 |
0.0000 |
| 446 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 447 |
SKIN LESION |
1 |
0.0000 |
| 448 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 449 |
CARDIAC ARREST |
3 |
0.0000 |
| 450 |
TREATMENT FAILURE |
3 |
0.0000 |
| 451 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 452 |
TREMOR |
6 |
0.0000 |
| 453 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 454 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 455 |
DEMENTIA |
1 |
0.0000 |
| 456 |
WOUND |
1 |
0.0000 |
| 457 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 458 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 459 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 460 |
DYSPHONIA |
2 |
0.0000 |
| 461 |
PALPITATIONS |
4 |
0.0000 |
| 462 |
TACHYCARDIA |
3 |
0.0000 |
| 463 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 464 |
JOINT SWELLING |
4 |
0.0000 |
| 465 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 466 |
STOMATITIS |
2 |
0.0000 |
| 467 |
EPILEPSY |
1 |
0.0000 |
| 468 |
INJECTION SITE RASH |
1 |
0.0000 |
| 469 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 470 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 471 |
CYSTITIS |
1 |
0.0000 |
| 472 |
HIP FRACTURE |
1 |
0.0000 |
| 473 |
FATIGUE |
24 |
0.0000 |
| 474 |
SWELLING FACE |
2 |
0.0000 |
| 475 |
OSTEONECROSIS |
1 |
0.0000 |
| 476 |
VIRAL INFECTION |
1 |
0.0000 |
| 477 |
SYNCOPE |
3 |
0.0000 |
| 478 |
URINARY RETENTION |
1 |
0.0000 |
| 479 |
GAIT INABILITY |
1 |
0.0000 |
| 480 |
INJURY |
2 |
0.0000 |
| 481 |
DYSPNOEA |
16 |
0.0000 |
| 482 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 483 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 484 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 485 |
BRONCHITIS |
2 |
0.0000 |
| 486 |
CHEST PAIN |
5 |
0.0000 |
| 487 |
HYPOAESTHESIA |
4 |
0.0000 |
| 488 |
ASTHENIA |
10 |
0.0000 |
| 489 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 490 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 491 |
HEADACHE |
16 |
0.0000 |
| 492 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 493 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 494 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 495 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 496 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 497 |
HYPOACUSIS |
1 |
0.0000 |
| 498 |
BALANCE DISORDER |
2 |
0.0000 |
| 499 |
DEHYDRATION |
3 |
0.0000 |
| 500 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 501 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 502 |
HYPOKALAEMIA |
1 |
0.0000 |
| 503 |
VOMITING |
10 |
0.0000 |
| 504 |
COMA |
1 |
0.0000 |
| 505 |
COLORECTAL CANCER |
1 |
0.0000 |
| 506 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 507 |
DIARRHOEA |
13 |
0.0000 |
| 508 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 509 |
THERAPY CESSATION |
1 |
0.0000 |
| 510 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 511 |
ECZEMA |
1 |
0.0000 |
| 512 |
DRUG INEFFECTIVE |
25 |
0.0000 |
| 513 |
OEDEMA |
1 |
0.0000 |
| 514 |
PRURITUS |
7 |
0.0000 |
| 515 |
URTICARIA |
3 |
0.0000 |
| 516 |
BLISTER |
1 |
0.0000 |
| 517 |
NAUSEA |
14 |
0.0000 |
| 518 |
MYALGIA |
3 |
0.0000 |
| 519 |
LETHARGY |
1 |
0.0000 |
| 520 |
SEIZURE |
2 |
0.0000 |
| 521 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 522 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 523 |
VERTIGO |
1 |
0.0000 |
| 524 |
DISCOMFORT |
1 |
0.0000 |
| 525 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 526 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 527 |
AMNESIA |
1 |
0.0000 |
| 528 |
RENAL FAILURE |
2 |
0.0000 |
| 529 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 530 |
VISION BLURRED |
2 |
0.0000 |
| 531 |
HYPERTENSION |
3 |
0.0000 |
| 532 |
CONSTIPATION |
3 |
0.0000 |
| 533 |
MALAISE |
6 |
0.0000 |
| 534 |
AGITATION |
1 |
0.0000 |
| 535 |
DYSGEUSIA |
1 |
0.0000 |
| 536 |
HALLUCINATION |
1 |
0.0000 |
| 537 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 538 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 539 |
PAIN |
8 |
0.0000 |
| 540 |
PARAESTHESIA |
2 |
0.0000 |
| 541 |
PROSTATE CANCER |
1 |
0.0000 |
| 542 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 543 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 544 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 545 |
ARTHRALGIA |
5 |
0.0000 |
| 546 |
FALL |
4 |
0.0000 |
| 547 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 548 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 549 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 550 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 551 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 552 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 553 |
BREAST CANCER |
1 |
0.0000 |
| 554 |
COUGH |
3 |
0.0000 |
| 555 |
ALOPECIA |
2 |
0.0000 |
| 556 |
HEART RATE INCREASED |
1 |
0.0000 |
| 557 |
DIZZINESS |
5 |
0.0000 |
| 558 |
SOMNOLENCE |
2 |
0.0000 |
| 559 |
SINUSITIS |
1 |
0.0000 |
| 560 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 561 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 562 |
HAEMORRHAGE |
1 |
0.0000 |
| 563 |
ASTHMA |
1 |
0.0000 |
| 564 |
FEELING ABNORMAL |
2 |
0.0000 |
| 565 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 566 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 567 |
WEIGHT DECREASED |
2 |
0.0000 |
| 568 |
ANXIETY |
2 |
0.0000 |
| 569 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 570 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 571 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 572 |
WEIGHT INCREASED |
1 |
0.0000 |
| 573 |
DEPRESSION |
1 |
0.0000 |
| 574 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 575 |
INSOMNIA |
1 |
0.0000 |
| 576 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 577 |
INJECTION SITE PAIN |
1 |
0.0000 |